CompletedPhase 3NCT00103168
Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor
Studying Gastrointestinal stromal tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Principal Investigator
- Paolo G. Casali, MDFondazione IRCCS Istituto Nazionale dei Tumori, Milano
- Intervention
- imatinib mesylate(drug)
- Enrollment
- 908 target
- Eligibility
- 18-120 years · All sexes
- Timeline
- 2004 – 2017
Study locations (30)
- Flinders Medical Centre, Bedford Park, South Australia, Australia
- Herlev University Hospital, Herlev, Denmark
- Centre Hospitalier d'Abbeville, Abbeville, France
- Centre Paul Papin, Angers, France
- Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz, Besançon, France
- Hopital Avicenne, Bobigny, France
- Institut Bergonie, Bordeaux, France
- Hopital Ambroise Pare, Boulogne-Billancourt, France
- C.H.U. de Brest, Brest, France
- Centre Regional Francois Baclesse, Caen, France
- Centre Jean Perrin, Clermont-Ferrand, France
- Hopital Louis Pasteur, Colmar, France
- Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France
- Centre Hospitalier de Dreux, Dreux, France
- Hopital Andre Mignot, Le Chesnay, France
- +15 more locations on ClinicalTrials.gov
Collaborators
Italian Sarcoma Group · UNICANCER · Grupo Espanol de Investigacion en Sarcomas
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00103168 on ClinicalTrials.govOther trials for Gastrointestinal stromal tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07171203Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal TumorUniversity of California, San Diego
- RECRUITINGNANCT07405125Safety of Robotic Surgery for GISTs at Special Anatomic SitesThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGPHASE3NCT07218926A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib TherapyGlaxoSmithKline
- RECRUITINGPHASE1NCT06655246A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Kura Oncology, Inc.
- RECRUITINGNANCT06926374Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic SurgeryChinese University of Hong Kong
- RECRUITINGNANCT07411118RCT of EFTR Versus STER for GIST TreatmentChinese University of Hong Kong
- RECRUITINGPHASE1, PHASE2NCT06630234A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)Deciphera Pharmaceuticals, LLC
- RECRUITINGPHASE3NCT06640361A Study of Olverembatinib in SDH-deficient GIST.Ascentage Pharma Group Inc.